Home/Filings/4/0001209191-23-002498
4//SEC Filing

Rawat Mohit 4

Accession 0001209191-23-002498

CIK 0001805890other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 6:45 AM ET

Size

5.3 KB

Accession

0001209191-23-002498

Insider Transaction Report

Form 4
Period: 2023-01-05
Rawat Mohit
President and CBO
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-01-05+300,000300,000 total
    Exercise: $3.75Exp: 2033-01-04Common Stock (300,000 underlying)
Footnotes (1)
  • [F1]This option vests in 48 equal monthly installments beginning on February 5, 2023.

Issuer

Fusion Pharmaceuticals Inc.

CIK 0001805890

Entity typeother

Related Parties

1
  • filerCIK 0001885800

Filing Metadata

Form type
4
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 6:45 AM ET
Size
5.3 KB